PT-3 GLP-1 Agonist
Diabetes/Obesity
Pre-clinicalActive
Key Facts
About Imagine Pharma
Imagine Pharma is a private, pre-clinical stage biotech leveraging a novel polypeptide (IMG-1) to build three distinct therapeutic platforms: Oral Delivery of biologics, novel Therapeutics, and Regenerative Medicine. Its pipeline includes early-stage programs for oral EPO, skin grafts, diabetic wounds, and autologous islet transplants for Type 1 Diabetes. The company appears to be pre-revenue, focusing on R&D and seeking partnerships to advance its broad portfolio of platform-derived programs.
View full company profileTherapeutic Areas
Other Diabetes/Obesity Drugs
| Drug | Company | Phase |
|---|---|---|
| DehydraTECH for GLP-1 | Lexaria Bioscience | Research |